These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 11679561)

  • 21. In vitro activities of a new lipopeptide antifungal agent, FK463, against a variety of clinically important fungi.
    Tawara S; Ikeda F; Maki K; Morishita Y; Otomo K; Teratani N; Goto T; Tomishima M; Ohki H; Yamada A; Kawabata K; Takasugi H; Sakane K; Tanaka H; Matsumoto F; Kuwahara S
    Antimicrob Agents Chemother; 2000 Jan; 44(1):57-62. PubMed ID: 10602723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro interactions of micafungin with amphotericin B against clinical isolates of Candida spp.
    Serena C; Mariné M; Quindós G; Carrillo AJ; Cano JF; Pastor FJ; Guarro J
    Antimicrob Agents Chemother; 2008 Apr; 52(4):1529-32. PubMed ID: 18227181
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Antifungal activity and clinical efficacy of micafungin (funguard)].
    Ikeda F
    Nihon Ishinkin Gakkai Zasshi; 2005; 46(4):217-22. PubMed ID: 16282962
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Antifungal activity and clinical efficacy of micafungin sodium (Funguard)].
    Ikeda F
    Nihon Yakurigaku Zasshi; 2003 Oct; 122(4):339-44. PubMed ID: 14501170
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro antifungal combination effects of micafungin with fluconazole, voriconazole, amphotericin B, and flucytosine against clinical isolates of Candida species.
    Nishi I; Sunada A; Toyokawa M; Asari S; Iwatani Y
    J Infect Chemother; 2009 Feb; 15(1):1-5. PubMed ID: 19280292
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The echinocandins.
    Cappelletty D; Eiselstein-McKitrick K
    Pharmacotherapy; 2007 Mar; 27(3):369-88. PubMed ID: 17316149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of hypoxic conditions on in vitro susceptibility testing of amphotericin B, itraconazole and micafungin against Aspergillus and Candida.
    Warn PA; Sharp A; Guinea J; Denning DW
    J Antimicrob Chemother; 2004 May; 53(5):743-9. PubMed ID: 15044422
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acquired resistance to echinocandins in Candida albicans: case report and review.
    Baixench MT; Aoun N; Desnos-Ollivier M; Garcia-Hermoso D; Bretagne S; Ramires S; Piketty C; Dannaoui E
    J Antimicrob Chemother; 2007 Jun; 59(6):1076-83. PubMed ID: 17468115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activity of a Long-Acting Echinocandin (CD101) and Seven Comparator Antifungal Agents Tested against a Global Collection of Contemporary Invasive Fungal Isolates in the SENTRY 2014 Antifungal Surveillance Program.
    Pfaller MA; Messer SA; Rhomberg PR; Castanheira M
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28052853
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of voriconazole combined with micafungin against Candida, Aspergillus, and Scedosporium spp. and Fusarium solani.
    Heyn K; Tredup A; Salvenmoser S; Müller FM
    Antimicrob Agents Chemother; 2005 Dec; 49(12):5157-9. PubMed ID: 16304192
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Morphological changes of Candida albicans induced by micafungin (FK463), a water-soluble echinocandin-like lipopeptide.
    Nishiyama Y; Uchida K; Yamaguchi H
    J Electron Microsc (Tokyo); 2002; 51(4):247-55. PubMed ID: 12227555
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antifungal activity of micafungin against Candida and Aspergillus spp. isolated from pediatric patients in Japan.
    Ikeda F; Saika T; Sato Y; Suzuki M; Hasegawa M; Mikawa T; Kobayashi I; Tsuji A
    Med Mycol; 2009 Mar; 47(2):145-8. PubMed ID: 18668422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Postantifungal effect of micafungin against Candida albicans, Candida dubliniensis and Candida africana in the presence and absence of serum.
    Kardos T; Saleh Q; Kovács R; Gesztelyi R; Kardos G; Bozó A; Tóth Z; Majoros L
    New Microbiol; 2017 Oct; 40(4):286-288. PubMed ID: 28994449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antifungal susceptibilities of the species of the Pseudallescheria boydii complex.
    Gilgado F; Serena C; Cano J; Gené J; Guarro J
    Antimicrob Agents Chemother; 2006 Dec; 50(12):4211-3. PubMed ID: 17015631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterizing the effects of caspofungin on Candida albicans, Candida parapsilosis, and Candida glabrata isolates by simultaneous time-kill and postantifungal-effect experiments.
    Clancy CJ; Huang H; Cheng S; Derendorf H; Nguyen MH
    Antimicrob Agents Chemother; 2006 Jul; 50(7):2569-72. PubMed ID: 16801448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Caspofungin-induced in-vitro post-antifungal effect and its impact on adhesion related traits of oral Candida dubliniensis and Candida albicans isolates.
    Ellepola AN; Chandy R; Khan ZU; Samaranayake LP
    Microbiol Immunol; 2016 Mar; 60(3):160-7. PubMed ID: 26850765
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Micafungin (FK463) on Candida albicans adherence to epithelial cells.
    Borg-von Zepelin M; Zaschke K; Gross U; Monod M; Müller FM
    Chemotherapy; 2002 Jul; 48(3):148-53. PubMed ID: 12138332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of Candida albicans CDR1, CDR2, or MDR1 does not produce significant changes in echinocandin susceptibility.
    Niimi K; Maki K; Ikeda F; Holmes AR; Lamping E; Niimi M; Monk BC; Cannon RD
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1148-55. PubMed ID: 16569823
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Caspofungin activity against clinical isolates of fluconazole-resistant Candida.
    Pfaller MA; Messer SA; Boyken L; Rice C; Tendolkar S; Hollis RJ; Diekema DJ
    J Clin Microbiol; 2003 Dec; 41(12):5729-31. PubMed ID: 14662968
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Micafungin sodium (FK-463).
    Fromtling RA
    Drugs Today (Barc); 2002 Apr; 38(4):245-57. PubMed ID: 12532193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.